Search results for "Albuminuria"

showing 4 items of 154 documents

Microalbuminuria and endothelial activation in treated and untreated diabetic and non-diabetic hypertensives

2004

medicine.medical_specialtymicroalbuminuriabiologybusiness.industryRenal functionendothelial activationmedicine.diseaseEndothelial activationEndocrinologyVon Willebrand factorDiabetes mellitusInternal medicineE-selectinInternal Medicinebiology.proteinmedicineadhesion moleculesMicroalbuminuriabusinessNon diabeticAmerican Journal of Hypertension
researchProduct

SHORT-TERM VARIABILITY OF 24H SYSTOLIC BLOOD PRESSURE IS ASSOCIATED WITH MICROALBUMINURIA IN PATIENTS WITH PRIMARY HYPERTENSION

2015

Objective: Limited and conflicting data are available about the association between shortterm blood pressure (BP) variability and urinary albumin excretion rate (uAER). The objective of our study was to analyze the relationships between microalbuminuria, defined as an uAER between 20 and 200mg/ min, and shortterm BP variability, assessed as average real variability (ARV), weighted standard deviation (SD) of 24h BP, and as SD of daytime and nighttime BP. Design and method: The study population consisted of 315 untreated essential hypertensives with normal estimated glomerular filtration rate (> 60ml/min/1.73 m2), which underwent 24h ambulatory BP monitoring and 24h uAER determination. Result…

microalbuminuriaessential hypertensionBPV
researchProduct

The Association of Microalbuminuria With Aortic Stiffness is Independent of C-Reactive Protein in Essential Hypertension

2009

microalbuminurialow-grade inflammationAortic Stiffne
researchProduct

GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art

2022

ABSTRACT Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are highly effective in improving glycaemic control either as monotherapy or in combination with other hypoglycaemic drugs, and have low incidence of side effects, such as hypoglycaemia, nausea and weight gain, thus increasing patients' adherence to therapy. Methods In this review we report the most recent studies demonstrating the beneficial effects of GLP-1RAs on renal outcomes, and also discuss the direct and indirect mechanisms through which they confer kidney protection. Finally, we discuss the metabolic and anti-inflammatory effects of GLP-1RAs in diabetic patients with COVID-19 disease. Results GLP-1RAs have a n…

nephroprotection.TransplantationGLP-1 receptor agonistNephrologyalbuminuriaCOVID-19 diseasediabetic kidney diseaseClinical Kidney Journal
researchProduct